DK3265459T3 - Amidforbindelser som 5-ht4-receptoragonister - Google Patents
Amidforbindelser som 5-ht4-receptoragonister Download PDFInfo
- Publication number
- DK3265459T3 DK3265459T3 DK16711355.4T DK16711355T DK3265459T3 DK 3265459 T3 DK3265459 T3 DK 3265459T3 DK 16711355 T DK16711355 T DK 16711355T DK 3265459 T3 DK3265459 T3 DK 3265459T3
- Authority
- DK
- Denmark
- Prior art keywords
- amid
- connections
- receptor agonists
- agonists
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN709CH2015 | 2015-02-13 | ||
PCT/IN2016/000008 WO2016128990A1 (en) | 2015-02-13 | 2016-01-07 | Amide compounds as 5-ht4 receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3265459T3 true DK3265459T3 (da) | 2019-07-15 |
Family
ID=55588327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16711355.4T DK3265459T3 (da) | 2015-02-13 | 2016-01-07 | Amidforbindelser som 5-ht4-receptoragonister |
Country Status (29)
Country | Link |
---|---|
US (1) | US9957257B2 (da) |
EP (1) | EP3265459B1 (da) |
JP (1) | JP6487564B2 (da) |
KR (1) | KR101966576B1 (da) |
CN (1) | CN107406434B (da) |
AU (1) | AU2016217461B2 (da) |
BR (1) | BR112017017275A2 (da) |
CA (1) | CA2975973C (da) |
CY (1) | CY1121898T1 (da) |
DK (1) | DK3265459T3 (da) |
EA (1) | EA034618B1 (da) |
ES (1) | ES2734734T3 (da) |
HR (1) | HRP20191179T1 (da) |
HU (1) | HUE045667T2 (da) |
IL (1) | IL253848B (da) |
LT (1) | LT3265459T (da) |
MA (1) | MA41633B1 (da) |
MD (1) | MD3265459T2 (da) |
ME (1) | ME03430B (da) |
MX (1) | MX368214B (da) |
NZ (1) | NZ734400A (da) |
PL (1) | PL3265459T3 (da) |
PT (1) | PT3265459T (da) |
RS (1) | RS59066B1 (da) |
SG (1) | SG11201706501VA (da) |
SI (1) | SI3265459T1 (da) |
TR (1) | TR201909997T4 (da) |
WO (1) | WO2016128990A1 (da) |
ZA (1) | ZA201705292B (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106831541B (zh) | 2011-11-18 | 2019-09-06 | 赫普泰雅治疗有限公司 | 毒蕈碱性m1受体激动剂 |
GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
GB201709652D0 (en) * | 2017-06-16 | 2017-08-02 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
CN110818661B (zh) * | 2019-12-02 | 2021-08-06 | 上海再启生物技术有限公司 | 5-ht4受体激动剂的关键中间体4-氨基-5-卤苯并呋喃-7-羧酸的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1689742B1 (en) | 2003-11-24 | 2010-03-17 | Pfizer, Inc. | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
WO2005092882A1 (en) | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders |
CA2598516C (en) | 2005-02-25 | 2010-05-11 | Pfizer Inc. | Benzisoxazole derivatives |
ES2333545T3 (es) | 2005-07-22 | 2010-02-23 | Pfizer, Inc. | Derivados de indazolcarboxamida como agonistas de receptores 5ht4. |
WO2007048643A1 (en) * | 2005-10-28 | 2007-05-03 | Glaxo Group Limited | Novel compound |
GB0525661D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Novel compounds |
GB0603550D0 (en) * | 2006-02-22 | 2006-04-05 | Glaxo Group Ltd | Novel compounds |
BR112012020060B8 (pt) * | 2010-02-12 | 2021-05-25 | Askat Inc | uso de n-((1-((4-hidroxitetrahidro-2h-piran-4-il)metil)piperidin-4-il)metil)-3-isopropil-2-oxo-2,3-dihidro-1h-benzo[d]imidazol-1-carboxamida para tratar doença de alzheimer e demência |
AU2011216950A1 (en) | 2010-02-16 | 2012-08-23 | Pfizer Inc. | (R)-4-((4-((4-(tetrahydrofuran-3-yloxy) benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors |
PL2758394T3 (pl) * | 2011-09-19 | 2015-08-31 | Suven Life Sciences Ltd | Związki heteroarylowe jako ligandy receptora 5-HT4 |
KR101815307B1 (ko) * | 2013-03-20 | 2018-01-04 | 수벤 라이프 사이언시스 리미티드 | 5-ht4 수용체 효능제로서 5-아미노-퀴놀린-8-카르복사미드 유도체 |
EA029951B1 (ru) * | 2013-12-16 | 2018-06-29 | Сувен Лайф Сайенсиз Лимитед | Соединения индазола в качестве агонистов 5-ht-рецептора |
-
2016
- 2016-01-07 PL PL16711355T patent/PL3265459T3/pl unknown
- 2016-01-07 EA EA201791829A patent/EA034618B1/ru unknown
- 2016-01-07 HU HUE16711355A patent/HUE045667T2/hu unknown
- 2016-01-07 NZ NZ734400A patent/NZ734400A/en not_active IP Right Cessation
- 2016-01-07 SG SG11201706501VA patent/SG11201706501VA/en unknown
- 2016-01-07 ME MEP-2019-190A patent/ME03430B/me unknown
- 2016-01-07 TR TR2019/09997T patent/TR201909997T4/tr unknown
- 2016-01-07 US US15/549,663 patent/US9957257B2/en active Active
- 2016-01-07 MX MX2017010348A patent/MX368214B/es active IP Right Grant
- 2016-01-07 SI SI201630311T patent/SI3265459T1/sl unknown
- 2016-01-07 KR KR1020177025584A patent/KR101966576B1/ko active IP Right Grant
- 2016-01-07 AU AU2016217461A patent/AU2016217461B2/en not_active Ceased
- 2016-01-07 MA MA41633A patent/MA41633B1/fr unknown
- 2016-01-07 JP JP2017542107A patent/JP6487564B2/ja not_active Expired - Fee Related
- 2016-01-07 PT PT16711355T patent/PT3265459T/pt unknown
- 2016-01-07 CN CN201680015614.4A patent/CN107406434B/zh not_active Expired - Fee Related
- 2016-01-07 EP EP16711355.4A patent/EP3265459B1/en active Active
- 2016-01-07 ES ES16711355T patent/ES2734734T3/es active Active
- 2016-01-07 LT LTEP16711355.4T patent/LT3265459T/lt unknown
- 2016-01-07 RS RS20190836A patent/RS59066B1/sr unknown
- 2016-01-07 CA CA2975973A patent/CA2975973C/en not_active Expired - Fee Related
- 2016-01-07 MD MDE20180052T patent/MD3265459T2/ro not_active IP Right Cessation
- 2016-01-07 DK DK16711355.4T patent/DK3265459T3/da active
- 2016-01-07 WO PCT/IN2016/000008 patent/WO2016128990A1/en active Application Filing
- 2016-01-07 BR BR112017017275A patent/BR112017017275A2/pt not_active IP Right Cessation
-
2017
- 2017-08-04 ZA ZA2017/05292A patent/ZA201705292B/en unknown
- 2017-08-06 IL IL253848A patent/IL253848B/en active IP Right Grant
-
2019
- 2019-07-01 HR HRP20191179TT patent/HRP20191179T1/hr unknown
- 2019-07-10 CY CY20191100739T patent/CY1121898T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3368060T3 (da) | Glugacon-receptor-agonister | |
DK3461821T3 (da) | Indolcarboxamidforbindelser, der er brugbar som kinasehæmmere | |
DK3302448T3 (da) | Erstattede heterocyclylafledninger som cdk-inhibitore | |
DK3319956T3 (da) | Substituerede oxopyridinderivater | |
DK3271358T3 (da) | Spirocykliske forbindelser som agonister af muscarin m1-receptor og/eller m4-receptor | |
DK3191450T3 (da) | Pyridonderivater som kinasehæmmere omarrangeret under transfektion (ret) | |
DK3406609T3 (da) | Bicykliske aza-forbindelser som muskariniske receptoragonister | |
DK3294713T5 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
DK3250586T3 (da) | Hidtil ukendte proteiner, som er specifikke for angiogenese | |
DK3094631T3 (da) | Pyrimidinyloxybenzenderivater som herbicider | |
DK3072835T3 (da) | Fremgangsmåde til fremføring | |
DK3265459T3 (da) | Amidforbindelser som 5-ht4-receptoragonister | |
DK3313838T3 (da) | Polycykliske amidderivater som cdk9-inhibitorer | |
DK3313832T3 (da) | 3-tetrazolyl-benzen-1,2-disulfonamidderivater som metallo-beta- lactamase-hæmmere | |
DK3331863T3 (da) | Hidtil ukendte forbindelser som ror-gamma-modulatorer | |
DK3325487T3 (da) | Formulering til bløde, anticholinerge analoger | |
DK3180329T3 (da) | Triazoler som nr2b receptorinhibitorer | |
DK3386500T3 (da) | Benzothiophen-baserede selektive østrogenreceptor ned-regulatorer | |
DK3458460T3 (da) | Imidazoler som histondemethylase-inhibitorer | |
DK3672951T3 (da) | Quinoxalinderivater som adenosinreceptorantagonister | |
DK3362444T3 (da) | Forbindelser | |
DK3371168T3 (da) | Indolin-2-on-derivater | |
DK3145916T3 (da) | Imidazolderivater som formylpeptidreceptormodulatorer | |
DK3661941T3 (da) | Thiazolopyridinderivater som adenosinreceptor-antagonister | |
DK3792251T3 (da) | Hidtil ukendte sulfonylaminobenzamidforbindelser som anthelmintika |